Incidence of lipoprotein (a) on residual vascular risk, after an acute coronary event
For an increasingly appropriate cardiac treatment
it
Prof. Savina Nodari
Arrhythmic storm: a complete panel of responses to reduce the risk of recurrence
it
Prof. Gaetano De Ferrari
Dyslipidemias, combination therapeutic strategies
it
Prof. Alberto Corsini
Incidence of lipoprotein (a) on residual vascular risk, after an acute coronary event
it
Prof. Francesco Barillà
Cardiac management of patients on hormone replacement therapy
it
Prof. Anna Vittoria Mattioli
Why ECG continues to be effective in assessing cardiovascular risk
it
Dott. Leonardo Calò
Three questions on the management of treatment with P2Y12 receptor inhibitors
it
Prof. Raffaele De Caterina
New therapeutic opportunities for cardiovascular risk containment
it
Prof. P. Perrone Filardi
Homozygous familial hypercholesterolemia, finally an effective therapy
it
Prof. Maurizio Averna
Tricuspid regurgitation, new options for non-invasive treatment
it
Prof. Francesco Grigioni
Heart failure: with the new echocardiography, better stratification of prognosis
it
Prof. Erberto Carluccio
Degenerated TAVI, what are the available treatments?
it
Dr. Carmen Spaccarotella